Moreover, a previous study has reported that in the presence of tumors, EV-enrichment may represent an epigenetic silencing mechanism whereby ccRCC maintains tumor development and growth by activating the PI3K/AKT pathway [32]. Here, AKT1 is linked to neoplasm.